Friday, October 19, 2012

Put an end to indignity AIDS bill

Put an end to indignity

Anand Grover
October 14, 2012First Published: 21:17 IST(14/10/2012)

Marred by disruptions and adjournments by the Opposition, the monsoon session of Parliament was a complete washout with minimal business being conducted. While the government took decades to table the much-hyped Lokpal Bill in Parliament, one wonders when important legislation like the HIV/Aids Bill, which aims to protect the rights of people living with the disease, will see the light of day.

From being forced out of schools to the denial of jobs to involuntary disclosure of HIV status, there's no end to discrimination that people living with HIV/Aids face. Not just this, their family members are also subjected to hostility, prejudice and stigma. Groups at risk of HIV like sex workers, men who have sex with men (MSM) and injecting drug users (IDUs) face rights violations in different spheres of their lives. However, only a few of these cases get reported.

With no specific anti-discrimination law to protect the rights of people living with and affected by HIV/Aids, there is limited legal redressal against rights violations faced by them. Unlike India, which is one of the earliest countries that started the process of drafting the HIV/Aids Bill, many, including 20 African nations, have passed laws on the disease. Earlier this year, the East African Assembly passed the HIV & Aids Prevention and Management Bill, 2012.

Among the Asian countries, the Philippines, Kazakhstan and Vietnam have specific HIV/Aids legislations.

Countries like South Africa, Australia, the US and Britain protect the rights of HIV positive people through anti-discrimination laws. The Disability Discrimination Act, 1992, in Australia covers not only HIV positive people but also those who are associated with HIV and those who are believed to have HIV. The Equality Act, 2010, of Britain protects HIV positive people from any kind of discrimination in both the public and private sectors.

In our country, after a series of consultations with all the stakeholders like people living with or at risk of HIV/Aids, doctors, lawyers, women's groups, children's rights groups and government officials, a draft Bill to that effect was finalised by the health ministry in July 2006. But till date it has not been tabled in Parliament.

The Bill seeks to protect people living with or at risk of HIV/Aids from discrimination, provides for informed consent for HIV testing, treatment and research, protects the confidentiality of HIV-related information including HIV testing and provides for complete and free HIV treatment for everyone in need of it.

It was first sent to the law ministry in August 2007. However, it took almost three years to clear the Bill and finally sent it back to the health ministry in March 2010. After that, in 2011, once again the health ministry sent the Bill to the law ministry. Even now, the Bill is pending with the law ministry and has not been sent to the Cabinet. For the last six years, people living with HIV/Aids and civil society organisations working in this field have been advocating the passing of this Bill.

Although the estimates of people with HIV/Aids have come down in our country, rights violation continues unabated. It's time the government displays some urgency on the issue and tables the Bill at the earliest so that people with HIV/Aids can lead a life of dignity.

Anand Grover is a senior advocate and director, Lawyers Collective, New Delhi

The views expressed by the author are personal
http://www.hindustantimes.com/News-Feed/ColumnsOthers/Put-an-end-to-indignity/Article1-944578.aspx
Pre-marital HIV testing is a shortcut to nowhere

Anand Grover & Mihir Samson Director & Advocacy Officer, Lawyers Collective

(The Maharashtra government's proposal is aimed at shielding women but it could end up adding to their vulnerability)

THE MAHARASHTRA government is considering a proposal to make HIV test mandatory before marriage. The proposal is seemingly an attempt to protect women from contracting HIV from their husbands. However, evidence shows that such testing is ineffective in preventing transmission.

The proposal is not new. It has been considered in Kerala (2011), Jharkhand (2010), Goa (2006), Andhra Pradesh (2002) and in Maharashtra itself in 2008. Each time, the proposal was abandoned or rejected for manifold reasons.

First and foremost, the National HIV/AIDS Control Programme, implemented by the health ministry's National AIDS Control Organisation (NACO), is founded on a rights-based approach. It is based on the understanding that the epidemic can be addressed only by respecting the rights of people living with HIV and those vulnerable.

Three fundamental aspects of this approach are informed consent, confidentiality and non-discrimination. When rights are violated, people lose confidence in the public health system, causing the epidemic to go underground.

Mandatory testing is antithetical to the rights-based approach. It overrides an individual's right to make decisions about their body and thereby violates their right to informed consent. There is also a serious risk of the HIV status of a person becoming public, violating their right to confidentiality. A large number of marriages in India are arranged with the participation of the prospective spouses' families. If a person tests positive, the results would be shared with everyone involved, thus making it public, with grave repercussions. There is also a risk of false positive results.

Persons who may not have contracted HIV may test positive, which could have a serious negative impact on their future.

Mandatory testing is also ineffective in preventing HIV transmission. It is based on a fundamentally flawed assumption that an HIV test prior to marriage guarantees protection from HIV subsequently as well.

It does not address the fact that HIV can be contracted during marriage, by either spouse, through extra-marital sex, blood transfusion or sharing needles. In fact, the test would lure spouses into a false sense of security of being protected from HIV.

This could increase complacency regarding health risks associated with sex and increase risky sexual activity. It would also reduce the ability of women to negotiate safe sex.

The public health system currently uses the antibody test to detect HIV. However, the limitation of the test is that there is a window period, of up to three months, during which antibodies remain below detection levels. During this period, an HIV positive person would test negative for HIV. As a result, HIV transmission would not be prevented when a person is tested during the window period.

Experience shows that mandatory pre-marital testing is easily subverted. When it was implemented in Illinois, US, people travelled to other states to get married. The law was later repealed. In Louisiana and Utah, similar laws were found to be wasteful and ineffective and eventually removed. In India, it is also possible that instituting such a policy could open a racket of obtaining false certificates.

It's possible that instituting such a policy could open a racket of obtaining false certificates

That women are more vulnerable to HIV than men is well-established. Part of this is biological, but a large part of this vulnerability can be traced to the socio-economic and cultural disadvantages that women face. Most women have little or no control over decisions about sex, including condom use.

It would be far better if NACO introduced the HIV/AIDS Bill in Parliament immediately. The Bill espouses the rights-based approach in general. It contains a number of specific provisions, seeking to ensure that women have access to information regarding, and able to take decisions relating to sex. These include the provision of sexuality education to adolescents and couple counselling before marriage. NACO must champion the cause of the Bill and put to bed all debate about policies such as mandatory pre-marital testing, which are contrary to the rights-based approach and deleterious to public health.

(The views expressed in this column are the writers' own)

letters@tehelka.com

http://www.tehelka.com/story_main54.asp?filename=Op201012Proscons.asp

Thursday, August 16, 2012

List of abbreviations HIV

List of abbreviations

AIDS- Acquired Immuno Deficiency Syndrome
ANC - Antenatal Cases
ART -C- Anti Retroviral Therapy Centre
BSS - Behavioral Surveillance Survey
CCC - Community Care Centre
CBO - Community Based Organization
DIC - Drop – In- Centre
DLN District Level Network
FBO - Faith Based Organization
FGD - Focus Group Discussion
FSW - Female Sex Worker
ICTC - Integrated Counseling and Testing Centre
KNP+ - Karnataka Network of Positive People
KSAPS - Karnataka State AIDS Prevention Society
LSE - Life Skills Education
LSC - Legal Services Centers
MSM Men having Sex with Men
NGO - Non Governmental Organization
NACP - National AIDS Control Programme
NACO - National AIDS Control Organization
OVC - Orphan and Vulnerable Children
OI - Opportunistic Infection
PHC - Primary Health Centre
PLHIV - People Living with HIV/AIDS
PPP - Public – Private - Partnership
STI - Sexually Transmitted Infection
TI - Targetted Intervention
TOT - Training of Trainers
TG - Transgender
TB - Tuberculosis
VH and SC - Village Health and Sanitation Committee

aids vaccine...

 International Aids Vaccine


International Aids Vaccine Initiative has now roped India into its global research network aiming to find an efficient vaccine against Aids, which infects one million people worldwide and kills more than 1,50,000 Indians.

A Rs 40-crore research centre set up jointly by IAVI and Transnational Health Sciences and Technology Institute under the department of biotechnology would start full-scale operations in another six months to study new strategies and design novel vaccine candidates.

“Vaccine is a preferred long term goal because for every two persons put on HIV treatment, five more become newly infected. Close to 46 per cent of HIV infected people in low and middle income countries do not have access to HIV medicine,”said Margaret McGlynn, president and CEO of IAVI.

The Indian laboratory comes after close to 100 Aids vaccine candidates worldwide failed to meet expectations in the last two decades, leaving the world with no Aids  vaccine despite early promises.

Out of 100 Aids vaccine candidates, only four went to large scale efficacy trial stage.

As many as 70 have been abandoned while 26 candidates are in trials, said Wayne Koff, chief scientific officer at IAVI.

Out of the remaining four candidates, two did not give desired results whereas trials on the remaining two are yet to be completed.

“All failures can be attributed to high level of variability in the human immunodeficiency virus. The outer protein in virus’s envelop in India differs by 25 per cent with that of the virus found in the USA. Because of the variability, it is difficult to make a vaccine against HIV,” Koff explained.

There is 10 per cent difference in structure and composition of envelop protein even in the HIV sub-type C found in India and South Africa.

Keeping the variability in mind, the new laboratory will focus on new strategies to develop a vaccine targeting those areas in HIV’s envelop which are conserved across strains.

“We hope to get going in a year as we are still in the stage of building the new centre. Though it will start functioning in another six months from a rented site, the centre will move to its final destination in the TSHTI in Faridabad in another two years,” said Sudhanshu Vrati, dean of TSHTI.
Source:- http://www.deccanherald.com/content/271688/aids-research-institute-come-up.html

hiv new drug from cipla

Cipla launches four in one drug for HIV patients

DIVYA RAJAGOPAL, ET Bureau Aug 14, 2012, 07.10PM IST
Tags:
MUMBAI: India's second largest drug company Cipla has launched Qvir, a combination of four HIV drugs in one single strip that would be used for a single day's treatment. The four drug kit contains Tenofovir and Emtricitabine and Atazanavir and Ritonavir. These drugs will be used for both first and second line treatment of HIV AIDS.
Cipla said by the end of 2010 close to 34 million people were living with HIV and that same year saw 2.7 million patients getting infected by the disease. "Every year about 5-10% of patients fail their first line treatment due to various reasons such as missing doses and the virus developing resistance", said Cipla